Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Of Enadenotucirev: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer.

NCT02028117 is registered in ClinicalTrials.gov with Akamis Bio as lead sponsor.

NCT NCT02028117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Of Enadenotucirev: Dose Finding and Proof of Concept in Platinum-Resistant Epithelial Ovarian Cancer.
Lead sponsor
Akamis Bio
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
November 19, 2019
Enrollment
38 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent platinum resistant ovarian cancer